METHOD FOR DIFFERENTIAL DIAGNOSTICS OF RECURRENT SQUAMOUS CELL TUMORS OF ORAL CAVITY WITH FIBROSIS AND HYPERKERATOSIS

• 1. 奈必洛尔在制备预防和/或治疗口腔白斑及口腔鳞状细胞癌的药物中的用途 [P] . 中国专利： CN113069443A . 2021-07-06
• 2. 口腔黏膜下纤维化恶性进展或其所致口腔癌的早期诊断和/或预后生物标志物的应用及产品 [P] . 中国专利： CN114045341A . 2022-02-15
• 3. METHOD FOR DIFFERENTIAL DIAGNOSTICS OF ACTINIC KERATOSIS AND SQUAMOUS CELL CARCINOMA OF SKIN [P] . 俄罗斯专利： RU2703464C1 . 2019-10-17

  机译： 皮肤性角化病和鳞状细胞癌的鉴别诊断方法

• 4. METHOD FOR ASSESSING METASTATIC INVOLVEMENT OF SIGNALLING LYMPH NODE IN EARLY FORMS OF SQUAMOUS CELL CARCINOMA OF ORAL CAVITY [P] . 俄罗斯专利： RU2732700C1 . 2020-09-21

  机译： 口腔鳞状细胞癌早期形态中信号淋巴结转移转移的评估方法

• 5. METHOD FOR TREATING Squamous cell carcinoma of the oral cavity and pharynx [P] . 俄罗斯专利： RU2018127510A . 2018-09-06

  机译： 口腔和咽部鳞状细胞癌的治疗方法

• 1. Levels of biological markers of nitric oxide in serum of patients with squamous cell carcinoma of the oral cavity [J] . Wioletta Ratajczak-Wrona, Ewa Jablonska, Bozena Antonowicz, 国际口腔科学杂志（英文版） . 2013,第003期
• 2. EGFR copy number alterations in primary tumors, metastatic lymph nodes, and recurrent and multiple primary tumors in oral cavity squamous cell carcinoma [J] . Shiang-Fu Huang, Huei-Tzu Chien, Sou-De Cheng, BMC Cancer . 2017,第1期
• 3. Metabolic tumor volume and total lesion glycolysis predict tumor progression and survival after salvage surgery for recurrent oral cavity squamous cell carcinoma [J] . Choi Woo Ri, Oh Jungsu S., Roh Jong-Lyel, Head and neck: Journal for the sciences and specialities of the head and neck . 2019,第6期
• 4. Intratumoral Heterogeneity in Recurrent Metastatic Squamous Cell Carcinoma of the Oral Cavity: New Perspectives Afforded by Multiregion DNA Sequencing and mtDNA Analysis [J] . Gabusi Andrea, Gissi Davide Bartolomeo, Tarsitano Achille, Journal of Oral and Maxillofacial Surgery . 2019,第2期
• 5. Low Dose Photofrin? PDT for Recurrent In-Situ Squamous Cell Tumors of the Head and Neck [C] . R R Allison, Austerlitz C, Sheng C, World congress of the International Photodynamic Association . 2009
• 6. E3 Ligase Identified by Differential Display (EDD) Enhances Cell Survival and Cisplatin Resistance in Epithelial Ovarian Cancer and Oral Squamous Cell Carcinoma. [D] . Bradley, Amber Thompson. 2014
• 7. EGFR copy number alterations in primary tumors metastatic lymph nodes and recurrent and multiple primary tumors in oral cavity squamous cell carcinoma [O] . Shiang-Fu Huang, Huei-Tzu Chien, Sou-De Cheng, 2017
• 8. PTEN and α-SMA Expression and Diagnostic Role in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma with Concomitant Oral Submucous Fibrosis [O] . Roshni Monteiro, Kaveri Hallikeri, Archana Sudhakaran 2021

• 1. Squamous cell carcinoma of the oral cavity and circulating tumour cells [J] . Johannes Wikner ,Alexander Grobe ,Klaus Pantel . 世界临床肿瘤学杂志：英文版 . 2014,第2期
• 2. Analysis of clinical symptoms and signs in cases of oral submucous fibrosis which have transformed into squamous cell carcinoma [J] . Xinchun Jian ,Xieshan Huang ,Deyu Liu . 口腔学期刊（英文） . 2013,第3期
• 3. Levels of biological markers of nitric oxide in serum of patients with squamous cell carcinoma of the oral cavity [J] . Wioletta Ratajczak-Wrona ,Ewa Jablonska ,Bozena Antonowicz . 国际口腔科学杂志 . 2013,第003期
• 4. Sphk1 Expression and Survival Outcomes in Squamous Cell Carcinoma of the Oral Cavity [J] . Brianna N. Harris ,Rizwan Masood ,Uttam K. Sinha . 癌症治疗（英文） . 2013,第3期
• 5. 有机阳离子转运蛋白3在口腔粘膜下纤维化背景下的颊鳞状细胞癌中的差异性表达 [C] . 胡玥 ,苏彤 ,陈文鑫 . 2017全国口腔生物医学学术年会 . 2017
• 6. COX-2在口腔乳头状瘤、口腔扁平苔藓及口腔鳞状细胞癌中的表达 [A] . 李雪 . 2011